View the Original article
Medical
Cannabinoids for major neurocognitive disorder: case report and literature review
Rev Colomb Psiquiatr. 2021 Jan-Mar;50(1):47-51. doi: 10.1016/j.rcp.2019.07.002. Epub 2020 Feb 3. ABSTRACT INTRODUCTION: Major neurocognitive disorder (MNCD) affects millions of people worldwide. However, the pharmacological options for its management are limited, ineffective and frequently associated Read more…